Stay updated on Fazirsiran in AATD Liver Disease Clinical Trial
Sign up to get notified when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.

Latest updates to the Fazirsiran in AATD Liver Disease Clinical Trial page
- Check3 days agoChange DetectedThe page now includes Alpha-1-antitrypsin deficiency as a topic and adds a Genetic and Rare Diseases Information Center resource under Resources.SummaryDifference0.2%

- Check10 days agoChange DetectedRemoved Alpha 1-antitrypsin deficiency and the Genetic and Rare Diseases Information Center resources from the page.SummaryDifference0.2%

- Check17 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed. This indicates a new version of the study documents (likely protocol/SPA) has been issued.SummaryDifference0.1%

- Check24 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 was added, replacing v3.4.1. This is a minor metadata update and does not alter study details, eligibility criteria, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision update: v3.4.0 → v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Fazirsiran in AATD Liver Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fazirsiran in AATD Liver Disease Clinical Trial page.